Patent application number | Description | Published |
20090056292 | PURGE EXHAUST PROCESSOR - A purge exhaust processor includes an inlet chamber receiving a purge exhaust. A portion of the purge exhaust including at least one of moisture, air, and oil is passed from the inlet chamber to a sump volume. A heat source changes a phase of the moisture from liquid to gas. A wick transfers the oil from the sump volume to an oil collector. | 03-05-2009 |
20100139487 | Purge Exhaust Processor - A purge exhaust processor includes an inlet chamber receiving a purge exhaust. A portion of the purge exhaust including at least one of moisture, air, and oil is passed from the inlet chamber to a sump volume. A heat source changes a phase of the moisture from liquid to gas. A wick transfers the oil from the sump volume to an oil collector. | 06-10-2010 |
20110303091 | SWEEP AIR SYSTEM FOR MEMBRANE AIR DRYER - A membrane dryer includes a shell having an inner tube and an outer tube and a bundle of hollow fibers supported in the shell. A dryer air inlet into the hollow fibers and a sweep air outlet from the inner tube are at a first end of the shell. A dryer air outlet into the hollow fibers and a sweep air inlet from the inner tube are at a second end of the shell. The inner tube has a first set of circumferential openings into the sweep air space adjacent the first end of the shell and a second set of circumferential openings into the sweep air space adjacent the first end of the shell; and a second plug is in the inner tube between the first and second set of openings. | 12-15-2011 |
20130319232 | PURGE EXHAUST PROCESSOR - A purge exhaust processor includes an inlet chamber, a sump chamber, a selectively charged surface in the inlet chamber, and an orifice. The inlet chamber receives purge exhaust including at least one of air, water vapor, oil aerosol, and water aerosol. The selectively charged surface agglomerates at least one of the oil aerosol and water aerosol into a liquid. The orifice is sized for passing the agglomerated liquid from the inlet chamber to the sump chamber. | 12-05-2013 |
Patent application number | Description | Published |
20100016336 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 01-21-2010 |
20100069448 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 03-18-2010 |
20110212951 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 09-01-2011 |
20120077853 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising one or more human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 03-29-2012 |
20120077975 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHOD OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 03-29-2012 |
20130023542 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 01-24-2013 |
20130023543 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 01-24-2013 |
20130096140 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 04-18-2013 |
20130324558 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 12-05-2013 |
20140221666 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 08-07-2014 |
20150104348 | Pet Deodorizing Composition - A deodorizing composition that entraps and neutralizes malodors and is intended to be used on a pet. The deodorizing composition contains cyclodextrin, an aqueous carrier, a water soluble silicone, and a buffer system comprising citric acid. The composition has a pH from about 5 to about 8.5 and the composition is non-irritating and non-toxic to pets. | 04-16-2015 |
20150210656 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE - The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-β) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-β) inhibitors, and to methods for regulating angiogenesis. | 07-30-2015 |